Full Press Release Details
In recognition of their innovation, business impact and commitment to improving patient outcomes, 40 biotech and pharma professionals have been named to the inauguralBioSpace40 Under 40list. The cohort includes winners from a range of areas and disciplines, including clinical, computational science, management, manufacturing, marketing, regulatory, and science/research and development.
“These individuals demonstrate why the biopharma industry will continue to persevere—determination to improve health through innovation, creativity and leading with conviction,” saidBioSpaceCEO Josh Goodwin. “Their outstanding careers, entrepreneurship and achievements are a testament to the grit of our industry.”
Of the honorees, 16 are CEOs, 16 founded or co-founded their company and six are vice presidents.
The inaugural 40 Under 40 cohort’s accomplishments include:
Nominations for 40 Under 40 were open from May 1 to Aug. 1. To be eligible, nominees had to be based in the U.S.; be 39 years of age or younger during the calendar year for which they were considered; work in a leadership role in any size company in biotech or pharma operating in the U.S.; and be employed at the company for which they were nominated when winners are announced.
View the full list of winnershere.